<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060952</url>
  </required_header>
  <id_info>
    <org_study_id>26/19 S-SR</org_study_id>
    <nct_id>NCT05060952</nct_id>
  </id_info>
  <brief_title>Calprotectin in Chronic Prosthetic Joint Infection</brief_title>
  <official_title>Synovial Fluid Calprotectin Lateral Flow Test for the Diagnosis of Prosthetic Joint Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A bacterial infection of an artificial joint is a serious complication that often requires&#xD;
      additional surgery to exchange the arthroplasty. It is also difficult to recognize an&#xD;
      infected joint, as the symptoms caused by the infection are very similar to those of other&#xD;
      problems with arthroplasties, such as loosening of the implant. To improve the ability to&#xD;
      diagnose prosthetic joint infections, this study compares the levels of calprotectin, a&#xD;
      specific inflammatory protein, in the joint fluid of infected joints and joints with other&#xD;
      complications. The underlying hypothesis is that the level of calprotectin in infected joints&#xD;
      is significantly higher, thus facilitating the diagnosis of prosthetic joint infection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of synovial fluid calprotectin</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>The level of synovial fluid calprotectin measured in joint fluid aspirate as a diagnostic test for prosthetic joint infection. The accuracy is calculated by comparing its results with the International Consensus Meeting (ICM) on prosthetic joint infection criteria of 2018.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Prosthetic Joint Infection</condition>
  <condition>Prosthetic Infection</condition>
  <condition>Arthroplasty Complications</condition>
  <arm_group>
    <arm_group_label>PJI</arm_group_label>
    <description>Patients with septic arthroplasty failure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aseptic</arm_group_label>
    <description>Patients with aseptic causes of arthroplasty failure</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Calprotectin Lateral Flow Test</intervention_name>
    <description>Semiquantitative point of care photometric assay for the calprotectin level in joint fluid aspirate</description>
    <arm_group_label>Aseptic</arm_group_label>
    <arm_group_label>PJI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with painful or failed arthroplasty of the hip or knee joint scheduled for partial&#xD;
        or complete arthroplasty exchange.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled arthroplasty exchange for any of the following reasons:&#xD;
&#xD;
          -  infection&#xD;
&#xD;
          -  loosening&#xD;
&#xD;
          -  instability&#xD;
&#xD;
          -  malalignment&#xD;
&#xD;
          -  periprosthetic fracture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute prosthetic joint infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christian Suren, M.D.</last_name>
    <phone>+49 89 4140</phone>
    <phone_ext>2271</phone_ext>
    <email>christian.suren@tum.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Suren, M.D.</last_name>
      <phone>+49 89 4140</phone>
      <phone_ext>2271</phone_ext>
      <email>christian.suren@tum.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 19, 2021</study_first_submitted>
  <study_first_submitted_qc>September 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 19, 2021</last_update_submitted>
  <last_update_submitted_qc>September 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität München</investigator_affiliation>
    <investigator_full_name>Christian Suren</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Arthritis, Infectious</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

